Table 2.
Batch 1 | Batch 2 | Targeted biomolecules | Steps |
---|---|---|---|
Lysate (100 µgx1) | Lysate (100 µgx1) | HA, CS, HS, peptides | i, ii, iii, iv |
Hyaluronan (100 µgx1) | Hyaluronan (100 µgx1) | HA | i |
Syndecan-1 (20 µgx1) | Syndecan-2 (20 µgx1) | CS, HS (only for batch1),peptides | ii, iii, iv |
Aggrecan (20 µgx1) | Aggrecan (20 µgx1) | CS, peptides | ii, iv |
Neurocan (20Ugx1) | - | CS, peptides | ii, iv |
HSBK (100 µgx1) | HSBK (100 µgx1) | HS | iii |
HSPIM (100 µgx1) | HSPIM (100 µgx1) | HS | iii |
AGP (30 µgx1) | AGP (30 µgx1) | peptides | iv |